Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors

Oncogene volume 20, pages 4984–4994 (2001)Cite this article

Abstract

MYC proto-oncogenes play a major role in various types of human tumors. The products of these genes are transcription factors that bind to specific sequences and activate the expression of target genes. Identifying these target genes and their downstream effectors is a crucial step in understanding and preventing MYC induced oncogenesis. Until now, most of the efforts to identify such genes were performed by analysing in vitro systems whose relevance to the malignant process in vivo remains unclear. We aimed at identifying genes that play a major role in the malignant process of MYC induced carcinogenesis. Thus, we analysed the expression profiles of human MYC induced tumors and compared them to similar, non-MYC tumors. Moreover, we looked for the common characteristics of different types of MYC induced tumors. We identified several genes, most of them involved in cell cycle regulation, that are over expressed in MYC induced lymphomas as well as MYC induced neuronal-like tumors. In order to determine whether MYC induced oncogenesis is similar in human and in the mouse model system, we analysed the expression of the identified genes in cells derived from transgenic mice tumors. We also present the distribution of MYC putative binding sites in the regulatory sequences of the genes identified in our analysis. This analysis pointed to two genes (E2F1 and TSC2) as candidates to be targets of Myc activity. We thus further analysed the expression of these genes in the tumor cell lines, and examined the plausibility that elements in their promoter bind the Myc protein. Our data points to several genes that may be involved in c-MYC and N-MYC induced tumors and to two genes that may be targets for MYC activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

BL:

Burkitt's lymphoma

NB:

neuroblastoma

NE:

neuroepithelyoma

MYC-ER:

a chimeric construct of c-MYC and the estrogen receptor

EMSA:

electrophoretic mobility shift assay

References

  • Adams MR, Sears R, Nuckolls F, Leone G, Nevins JR . 2000 Mol. Cell. Biol. 20: 3633–3639

  • Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H . 1992 Nature 359: 423–426

  • Ben-Bassat H, Polliack A, Shlomai Z, Kohn G, Hadar R, Rabinowitz R, Leizerowitz R, Matutes E, Buchier V, Brok-Simoni F, Okon E, Livni N, Schleisinger M . 1992 Leuk. Lymph. 6: 513–521

  • Ben-Porath I, Yanuka O, Benvenisty N . 1999 Mol. Cell. Biol. 19: 3529–3539

  • Ben-Yosef T, Yanuka O, Halle D, Benvenisty N . 1998 Oncogene 17: 165–171

  • Bishop JM . 1987 Science 235: 305–311

  • Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H . 1990 Science 250: 1149–1151

  • Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM . 1984 Science 224: 1121–1124

  • Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW . 1992 Genes Dev. 6: 2248–2257

  • Claassen GF, Hann SR . 1999 Oncogene 18: 2925–2933

  • Cole MD . 1986 Annu. Rev. Genet. 20: 361–384

  • Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, Golub TR . 2000 Proc. Natl. Acad. Sci. USA 97: 3260–3265

  • Dang C . 1999 Mol. Cell. Biol. 19: 1–11

  • Dang CV, Lewis BC, Dolde C, Dang G, Shim H . 1997 J. Bioenerg. Biomembr. 29: 345–354

  • Davis AC, Wims M, Spotts GD, Hann SR, Bradley A . 1993 Genes Dev. 7: 671–682

  • Davis L, Halazonetis T . 1993 Oncogene 8: 125–132

  • Escot C, Theillet C, Lidereau R, Spyratos F, Champeme MH, Gest J, Callahan R . 1986 Proc. Natl. Acad. Sci. USA 83: 4834–4838

  • Evan GI, Littlewood TD . 1993 Curr. Opin. Gene Dev. 3: 44–49

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC . 1992 Cell 69: 119–128

  • Facchini LM, Penn LZ . 1998 FASEB J. 12: 633–651

  • Freytag SO . 1988 Mol. Cell. Biol. 8: 1614–1624

  • Gandarillas A, Watt FM . 1997 Genes Dev. 11: 2869–2882

  • Gomez M, Sampson J, Whittemore V . 1999 The Tuberous Sclerosis Complex Oxford University Press: Oxford, United Kingdom

    Google Scholar 

  • Grandori C, Eisenman RN . 1997 Trends Biochem. Sci. 22: 177–181

  • Guerin M, Barrois M, Terrier MJ, Spielman M, Riou G . 1988 Oncogene Res. 3: 21–31

  • Klein G, Giovanella B, Westman A, Stehlin JS, Mumford D . 1975 Intervirology 5: 319–334

  • Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H . 1991 Cell 66: 305–315

  • Leder P, Battey J, Lenoir G, Moulding C, Murphy W, Potter H, Stewart T, Taub R . 1983 Science 222: 765–771

  • Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR . 2000 Mol. Cell. Biol. 20: 3626–3632

  • Malynn BA, de Alboran IM, O'Hagan RC, Bronson R, Davidson L, DePinho RA, Alt FW . 2000 Genes Dev. 14: 1390–1399

  • Marcu KB, Bossone SA, Patel AJ . 1992 Annu. Rev. Biochem. 61: 809–860

  • Marhin W, Chen S, Facchini L, Fornace Jr AJ, Penn L . 1997 Oncogene 14: 2825–2834

  • Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD . 1985 Nature 318: 69–73

  • Nesbit CE, Tersak JM, Prochownik EV . 1999 Oncogene 18: 3004–3016

  • O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelman JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, Meltzer P, DePinho RA . 2000 Nature Genet. 24: 113–119

  • Obaya AJ, Mateyak MK, Sedivy JM . 1999 Oncogene 18: 2934–2941

  • Onda H, Lueck A, Marks PW, Warren HB, Kwiatkowski DJ . 1999 J. Clin. Invest. 104: 687–695

  • Oswald F, Lovec H, Moroy T, Lipp M . 1994 Oncogene 9: 2029–2036

  • Prendergast GC . 1999 Oncogene 18: 2967–2987

  • Prendergast GC, Ziff EB . 1992 Trends. Genet. 8: 91–96

  • Pulvertaft FJV . 1965 J. Clin. Path. 18: 261–266

  • Sadee W, Yu VC, Richards ML, Preis PN, Schwab MR, Brodsky FM, Biedler JL . 1987 Cancer Res. 47: 5207–5212

  • Sambrook J, Fritsch E, Maniatis T . 1989 Molecular Cloning: A Laboratory Manual second edition Cold Spring Harbor Laboratory Press

    Google Scholar 

  • Schmidt EV . 1999 Oncogene 18: 2988–2996

  • Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J . 1983 Nature 305: 245–248

  • Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P . 1987 Cell 49: 465–475

  • Soucek T, Yeung RS, Hengstschlager M . 1998 Proc. Natl. Acad. Sci. USA 95: 15653–15658

  • Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF . 1992 Genes Dev. 6: 2235–2247

  • Steinitz M, Klein G . 1975 Proc. Natl. Acad. Sci. USA 72: 3518–3520

  • Stewart TA, Pattengale PK, Leder P . 1984 Cell 38: 627–637

  • Wienecke R, Konig A, DeClue JE . 1995 J. Biol. Chem. 270: 16409–16414

  • Wiman KG, Clarkson B, Hayday AC, Saito H, Tonegawa S, Hayward WS . 1984 Proc. Natl. Acad. Sci 81: 6798–6802

  • Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS . 1997 J. Biol. Chem. 272: 6097–6100

  • Yeger H, Baumal R, Pawlin G, Tonin P, Nissen L, Kaplinsky C, Phillips MJ . 1988 Differentiation 39: 216–227

  • Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran AD, Gee CE, Minna JD, Alt FW . 1986 Nature 319: 780–783

Download references

Acknowledgements

We thank Dr Uzi Motro for his help in formulating equation (1). We thank the members of our laboratory for their critical reading of the manuscript. This research was supported by grant#98-00074 from the United States–Israel Bi-national Science Foundation (BSF), Jerusalem, Israel and by a grant from the Israel Cancer Research Fund. O Schuldiner is a Clore fellow.

Author information

Authors and Affiliations

  1. Department of Genetics, The Silberman Institute for Life Sciences, The Hebrew University, Givat-Ram, Jerusalem, 91904, Israel

    Oren Schuldiner & Nissim Benvenisty

Authors
  1. Oren Schuldiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nissim Benvenisty
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schuldiner, O., Benvenisty, N. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 20, 4984–4994 (2001). https://doi.org/10.1038/sj.onc.1204459

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204459

Keywords

Search

Advanced search

Quick links